This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Spravato
  • /
  • A Long-term Comparison of Esketamine Nasal Spray V...
Clinical trial

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive D

Read time: 1 mins
Last updated:10th Jan 2021
Status: Recruiting
Identifier: NCT04338321
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest